ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,484.75
0.44%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

  7. RegeneRX Biopharmaceuticals Inc (CE) (RGRX) News

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:RGRX
DateTimeSourceHeadlineSymbolCompany
14/08/202321:01Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/08/202320:57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/07/202322:13Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/07/202322:19Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202321:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
26/06/202311:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
21/06/202311:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/05/202321:25Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/04/202321:32Edgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
14/11/202221:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
12/08/202221:16Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202222:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202222:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202222:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202222:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202222:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
16/05/202222:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/11/202121:35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/11/202119:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/10/202111:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
08/10/202120:52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
17/08/202115:32Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/08/202121:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202121:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202121:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202121:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
04/08/202121:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
22/07/202122:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/07/202121:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:RGRX

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
ENET
Ethernity Networks
LSE
GKP
Gulf Keystone Petroleum
LSE
ARCM
Arc Minerals
LSE
PHNX
Phoenix
LSE
NEXN
Nexxen
LSE
SRSP
Sirius Petroleum
LSE
NSCI
Netscientific
LSE
EEE
Empire Metals
LSE
LGEN
Legal & General
LSE
SBTX
Skinbiotherapeutics
LSE
FUM
Futura Medical
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved